close 73% inwestorów detalicznych traci pieniądze podczas handlu CFD z tym dostawcą. Inwestowanie wiąże się z ryzykiem i nie jest odpowiednie dla wszystkich inwestorów. Kontrakty CFD są złożonymi instrumentami i wiążą się z dużym ryzykiem szybkiej utraty środków pieniężnych z powodu dźwigni finansowej. 73% rachunków inwestorów detalicznych notuje stratę pieniędzy podczas handlu kontraktami CFD z tym dostawcą. Upewnij się, czy rozumiesz, jak działają kontrakty CFD, i czy możesz pozwolić sobie na wysokie ryzyko utraty pieniędzy.
Change languagePolski
Pulpit

LLY

922.39

-1.51%↓

JNJ

186.29

-0.03%↓

UNH

324.11

+0.82%↑

NVS

126.28

-0.09%↓

ABT

126.19

+1.02%↑

LLY

922.39

-1.51%↓

JNJ

186.29

-0.03%↓

UNH

324.11

+0.82%↑

NVS

126.28

-0.09%↓

ABT

126.19

+1.02%↑

LLY

922.39

-1.51%↓

JNJ

186.29

-0.03%↓

UNH

324.11

+0.82%↑

NVS

126.28

-0.09%↓

ABT

126.19

+1.02%↑

LLY

922.39

-1.51%↓

JNJ

186.29

-0.03%↓

UNH

324.11

+0.82%↑

NVS

126.28

-0.09%↓

ABT

126.19

+1.02%↑

LLY

922.39

-1.51%↓

JNJ

186.29

-0.03%↓

UNH

324.11

+0.82%↑

NVS

126.28

-0.09%↓

ABT

126.19

+1.02%↑

Strona główna・Stock List・VIRIDIAN THERAPEUTICS INC
Search

VIRIDIAN THERAPEUTICS INC

Closed

SectorHealthcare

27.25 -1.02

Strong Buy

Price update 7 lis 2025, 20:59 UTC

BuySell

Overview

Share price change

24h

Current

Min

26.4

Max

27.51

Key metrics

By Trading Economics

Income

-14M

-101M

Sales

3K

75K

Profit margin

-134,313.333

Employees

143

EBITDA

-14M

-100M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+43.93% upside

Market Stats

By TradingEconomics

Market Cap

779M

2.2B

Previous open

28.27

Previous close

27.25

News Sentiment

By Acuity

50%

50%

183 / 374 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Very Strong Bearish Evidence

12 / 13.14 Support & Resistance

VIRIDIAN THERAPEUTICS INC Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

7 lis 2025, 21:06 UTC

Major Market Movers

JBS Down After Trump Calls for Probe into Meat-Packing Companies

DJ

Read

7 lis 2025, 22:36 UTC

Earnings

McDonald's Stock Challenged By a Tougher Economy, Analyst Says. Plus, Marriott, Snowflake, and More. -- Barrons.com

DJ

Read

7 lis 2025, 22:22 UTC

Earnings

The Score: GM, Tesla, Palantir, American Airlines and More Stocks That Defined the Week -- WSJ

DJ

Read

7 lis 2025, 22:03 UTC

Earnings

Constellation Software 3Q Rev $2.95B >CSU.T

DJ

Read

7 lis 2025, 22:03 UTC

Earnings

Constellation Software 3Q Net $210M >CSU.T

DJ

Read

7 lis 2025, 22:03 UTC

Earnings

Constellation Software 3Q EPS $9.89 >CSU.T

DJ

Read

7 lis 2025, 21:50 UTC

Market Talk

Financial Services Roundup: Market Talk

DJ

Read

7 lis 2025, 21:50 UTC

Market Talk

Health Care Roundup: Market Talk

DJ

Read

7 lis 2025, 20:59 UTC

Earnings

Palantir's CEO Says His Earnings Were the Best Ever. They Weren't Even the Best of the Week. -- Barrons.com

DJ

Read

7 lis 2025, 20:26 UTC

Market Talk

Natural U.S. Gas Futures Extend Rally to Three Weeks -- Market Talk

DJ

Read

7 lis 2025, 20:22 UTC

Earnings

Free-Spending Big Tech Dominates Earnings. As for the Rest: Don't Miss. -- Barrons.com

DJ

Read

7 lis 2025, 20:04 UTC

Market Talk

Oil Futures Close Choppy Week With Losses -- Market Talk

DJ

Read

7 lis 2025, 19:34 UTC

Market Talk

Gold Posts Small Gain for Week -- Market Talk

DJ

Read

7 lis 2025, 19:31 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Prices of Gas-Fired Power Plants Have Room to Grow -- Market Talk

DJ

Read

7 lis 2025, 19:17 UTC

Earnings

These Stocks Are Moving the Most Today: Tesla, Expedia, Take-Two, Block, Affirm, Sunrun, Globus Medical, JFrog, and More -- Barrons.com

DJ

Read

7 lis 2025, 19:09 UTC

Earnings

Wendy's Turnaround Won't Be Easy. Earnings, and the Stock, Tell the Story. -- Barrons.com

DJ

Read

7 lis 2025, 19:08 UTC

Earnings

KKR Defied Private-Equity Fundraising Slump in the Third Quarter -- WSJ

DJ

Read

7 lis 2025, 18:31 UTC

Market Talk

U.S. Oil RIg Count Unchanged at 414 -- Market Talk

DJ

Read

7 lis 2025, 17:27 UTC

Market Talk

EPA Announces New Exemptions to Biofuel Blending Rules -- Market Talk

DJ

Read

7 lis 2025, 17:20 UTC

Market Talk

Eli Lilly GLP-1 Deal with Trump Administration Provides Net Boost -- Market Talk

DJ

Read

7 lis 2025, 17:20 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

DJ

Read

7 lis 2025, 17:20 UTC

Market Talk

Financial Services Roundup: Market Talk

DJ

Read

7 lis 2025, 17:20 UTC

Market Talk

Health Care Roundup: Market Talk

DJ

Read

7 lis 2025, 17:17 UTC

Acquisitions, Mergers, Takeovers

Satair Expects to Complete Purchase in Early 2026

DJ

Read

7 lis 2025, 17:17 UTC

Acquisitions, Mergers, Takeovers

Satair: Deal Includes Unical's and ecube's Seven Operational Sites and Offices, With Combined 2024 Rev of $298M and Headcount of 413

DJ

Read

7 lis 2025, 17:15 UTC

Acquisitions, Mergers, Takeovers

Airbus Unit Satair to Buy Unical Aviation From Platinum Equity

DJ

Read

7 lis 2025, 17:09 UTC

Market Talk

PENN Is Falling Further Behind Competitors -- Market Talk

DJ

Read

7 lis 2025, 16:49 UTC

Market Talk

Losing ESPN Partnership Will Hurt PENN -- Market Talk

DJ

Read

7 lis 2025, 16:24 UTC

Market Talk

OPEC+'s Output Hike Pause Comes Amid Excess Supply, Lower Spare Capacity -- Market Talk

DJ

Read

7 lis 2025, 16:17 UTC

Market Talk

Oil Market Faces Oversupply But "Glut" Might Be Overblown -- Market Talk

DJ

Read

Peer Comparison

Price change

VIRIDIAN THERAPEUTICS INC Forecast

Price Target

By TipRanks

43.93% upside

12 Months Forecast

Average 39.58 USD  43.93%

High 61 USD

Low 13.948 USD

Based on 14 Wall Street analysts offering 12 month price targets forVIRIDIAN THERAPEUTICS INC - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

14 ratings

14

Buy

0

Hold

0

Sell

Based on 14 analysts giving stock ratings to VIRIDIAN THERAPEUTICS INC - Dist in the past 3 months.

Technical Score

By Trading Central

12 / 13.14Support & Resistance

Short Term

Very Strong Bearish Evidence

Recent bearish events outweigh bullish events.

Intermediate Term

Bearish Evidence

All events are bearish.

Long Term

Strong Bearish Evidence

All events are bearish.

Sentiment

By Acuity

183 / 374 Ranking in Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

Other stocks from the sector

LLY

Eli Lilly and Co.

922.39

↓-1.51%

JNJ

Johnson and Johnson

186.29

↓-0.03%

UNH

UnitedHealth Group Inc

324.11

↑ +0.82%

NVS

Novartis AG

126.28

↓-0.09%

ABT

Abbott Laboratories

126.19

↑ +1.02%
help-icon Live chat